Clinical Trial Update: Prospective, Double Blind, Placebo Control, Bariatric IV Ace [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an intravenous agent (IV Ace) used in obesity; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• IV Ace

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2018-04-20